Considerations for RT-qPCR in molecular point of care testing devices

Considerations for RT-qPCR in molecular point of care testing devices

The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.

Read more

The BiosearchTech Blog

Most popular

Extensions to the IVDR - what diagnostics manufacturers and suppliers need to know

Posted on Thu, Dec 02, 2021 @ 03:25 PM

We're excited to announce that the proposal to extend certain key provisions of the In Vitro Diagnostic Regulation ...
Read more

Topics: Molecular Diagnostics, IVDR

The surprising global impacts of Europe's In Vitro Diagnostic Regulation (IVDR)

Posted on Thu, Sep 16, 2021 @ 10:15 AM

A shortcut to understanding how to prepare for IVDR In today’s global environment, even small regulatory changes in one ...
Read more

Topics: Molecular Diagnostics, IVDR

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!